New biologic aortic valve replacement study
Part of Genetic & congenital, Heart & circulation clinical trials.
This study is testing a new generation of biologic (tissue) replacement valves for the aortic valve in adults aged 18 to 65. It aims to see how well these newer devices work compared to standard options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are eligible for surgery to replace your aortic valve (the main heart valve that sends blood to your body) with a biologic valve (made from tissue).
- This includes replacing your own valve or replacing an existing artificial biologic valve.
- You are not planning to get a mechanical (metal) valve.
- You do not need surgery on another heart valve or a catheter-based procedure (like TAVR).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to replace a narrowed heart valve in people with a bicuspid aortic valve. If you're 50 or older and need a new valve, this study can help figure out which approach works best.
This study tests a new replacement valve for the aortic valve, which controls blood flow from the heart. It may help people with severe aortic valve narrowing or leaking who need surgery.
This study is testing a new heart valve called Dafodil to see how safe and effective it is for people who need their aortic or mitral valve replaced. It aims to help improve heart function and quality of life.
This trial compares two newer types of replacement heart valves (SAPIEN 3 Ultra Resilia and Evolut FX) to see which one works better for people with severe aortic stenosis, a condition where the heart's main valve becomes narrow. If you join, you'll be randomly assigned to receive one of the two valves during your TAVI procedure.
This study tests a biological (tissue) heart valve replacement system designed to be easier to change later. It may help people who need valve surgery because their valve is narrowed or damaged.
This study tests a new replacement valve for the aortic heart valve, delivered through a catheter (a thin tube) — a procedure called TAVR. It is for people who have severe aortic stenosis and are not good candidates for open-heart surgery.
Hear when a new Aortic Regurgitation Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.